West Pharmaceutical Services, Inc.
WST
$251.38
$0.130.05%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 0.20% | -1.58% | -7.09% | -17.85% | -16.97% |
| Total Depreciation and Amortization | 10.30% | 9.63% | 11.09% | 13.09% | 13.18% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 312.50% | -66.45% | -85.46% | -100.00% | -96.37% |
| Change in Net Operating Assets | 2,651.72% | 242.86% | -37.82% | 558.54% | 114.22% |
| Cash from Operations | 15.52% | -1.22% | -10.06% | -12.16% | -15.85% |
| Capital Expenditure | 24.16% | 17.36% | 15.84% | 3.45% | -4.14% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 105.26% | 30.00% | 74.63% | 74.63% |
| Cash from Investing | 24.50% | 17.79% | 15.87% | 4.72% | -2.71% |
| Total Debt Issued | -- | -100.00% | 270.57% | -- | -- |
| Total Debt Repaid | 99.43% | 99.53% | -121.89% | -7,572.00% | -7,912.50% |
| Issuance of Common Stock | -44.34% | -48.93% | -60.30% | -61.33% | -35.88% |
| Repurchase of Common Stock | 75.86% | 72.25% | 63.37% | 34.02% | -25.58% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.55% | -3.58% | -3.44% | -3.47% | -3.68% |
| Other Financing Activities | -110.00% | -- | -- | -- | -- |
| Cash from Financing | 70.27% | 67.40% | 57.89% | 24.41% | -35.47% |
| Foreign Exchange rate Adjustments | 207.01% | -95.57% | 401.96% | 2.33% | -287.72% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 183.05% | 133.75% | 118.14% | 30.54% | -814.11% |